<DOC>
	<DOC>NCT01201070</DOC>
	<brief_summary>General and specific objectives of the search: evaluate the effects of the administration of Antithrombin III (ATIII) on the activation of the coagulation system and of the fibrinolysis, platelet function, inflammatory response and markers of organ damage in patients undergoing cardiac surgery by cardiopulmonary bypass (CPB) with low plasma levels of post-operative Antithrombin (AT).</brief_summary>
	<brief_title>Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Stenosis</mesh_term>
	<mesh_term>Antithrombins</mesh_term>
	<mesh_term>Antithrombin III</mesh_term>
	<criteria>All patients were candidates for cardiac surgery intervention in extracorporeal circulation positive history for allergic reactions to AT III cardiac surgery "OffPump" administration of AT during surgery or within 48 h treatment with drugs and nonsteroidal steroids within 48 h prior disorders of coagulation platelets &lt;30,000 preexisting IRC in dialysis treatment severe liver failure enlistment in another trial in the last 30 days hypothermia emergency reopening length of CEC&gt; 180 minutes subjects incapable of giving legal consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>